Introduction: A Laboratory Result Is the End of a Process, Not the Beginning
A laboratory result may appear on a clinical report as a single number, category, or interpretation, but that result is the product of a complex sequence of decisions and controlled activities. The process begins before a specimen reaches an analyzer and continues after the analytical measurement is complete.
In modern laboratory medicine, this end-to-end pathway is often described as the total testing process. International standards commonly organize it into preexamination, examination, and postexamination processes. Understanding these phases is essential because the clinical usefulness of a result depends not only on analytical performance, but also on correct test selection, patient identification, specimen integrity, result verification, communication, and appropriate interpretation.
This article follows a laboratory test from the initial clinical question to the final reported result and highlights the quality checkpoints that protect patients at every stage.
1. The Total Testing Process
The total testing process can be organized into three major phases:
- Preexamination: activities before the measurement itself, including the test request, patient preparation and identification, specimen collection, labeling, transport, receipt, processing, and assessment of specimen suitability.
- Examination: the analytical measurement or laboratory procedure, including instrument performance, reagents, calibration where applicable, quality control, method-specific procedures, and technical review.
- Postexamination: activities after measurement, including result review, authorization, reporting, communication of urgent findings, retention of specimens and records as applicable, and support for clinical interpretation.
These phases are interconnected. A technically excellent analytical method cannot correct a specimen collected from the wrong patient, and a correct result has limited value if it is reported to the wrong destination or an urgent finding is not communicated appropriately.
2. The Clinical Question and Test Request
The laboratory pathway begins with a clinical question. The requested test should be appropriate for the information needed, and the request must contain sufficient identifiers and clinical or administrative information to ensure that the correct examination is performed for the correct patient.
Test selection also matters because different examinations can require different specimen types, collection tubes, patient preparation, timing, transport conditions, and stability limits. A fasting chemistry measurement, therapeutic drug concentration, coagulation study, blood culture, and complete blood count do not share identical preexamination requirements.
Laboratory professionals therefore contribute to patient care before analysis begins by providing clear collection instructions, test requirements, rejection criteria, and consultation when a request is incomplete or potentially inappropriate.
3. Patient Identification: The First Safety Barrier
Correct patient identification is foundational. The person from whom the specimen is collected must be matched reliably with the request and the labels applied to the specimen. Identification procedures should follow institutional policy and applicable regulatory or accreditation requirements.
A specimen with excellent volume, appearance, and analytical stability is still unsafe if its identity is uncertain. For that reason, laboratories establish procedures for identifying patients, labeling specimens, documenting collection, and managing identification discrepancies.
4. Patient Preparation and Timing
Some measurands are affected by biological or behavioral variables before collection. Depending on the test, relevant factors can include fasting status, posture, recent physical activity, medication timing, circadian variation, recent intake, or the relationship of collection time to a therapeutic dose.
The goal is not to eliminate biological variation—much of it is intrinsic—but to control or document variables that could meaningfully alter interpretation. Collection instructions should therefore be test-specific rather than based on a single universal rule.
5. Specimen Collection
Collection is a technical procedure with direct consequences for result quality. For venous blood testing, considerations include selecting the appropriate collection device, verifying the required specimen and additive, minimizing collection-related injury or contamination, obtaining an adequate volume, labeling correctly, and following the laboratory's validated procedure.
CLSI PRE02, published in 2025, provides a stepwise framework for diagnostic venous blood specimen collection. The modern emphasis is not merely on performing venipuncture, but on integrating collection into a broader quality system.
The term specimen is preferred in many medical laboratory standards because the material collected from a patient is submitted for examination. In everyday educational language, the word sample is also frequently used; this article uses specimen when discussing formal laboratory processes.
6. Labeling and Traceability
Immediately after collection, the specimen must remain traceable to the correct patient and request. Traceability connects the specimen to its identity, collection information, accession or laboratory number, processing history, analytical system, result, and relevant records.
Barcode systems and laboratory information systems can reduce manual transcription, but technology does not replace procedural discipline. Laboratories still need defined processes for mislabeled, incompletely labeled, unlabeled, or otherwise nonconforming specimens.
7. Transport: Protecting the Specimen Before Analysis
After collection, the specimen enters a period in which time, temperature, agitation, light exposure, container characteristics, and delays can affect suitability. Transport conditions should be selected according to the specimen type and the examination being performed.
CLSI PRE04 emphasizes that specimen suitability can be measurand-specific: a condition that makes a specimen unsuitable for one examination may not necessarily make it unsuitable for every other examination requested from that specimen. This is why rejection decisions should be governed by validated criteria rather than by a single oversimplified rule.
Examples of preexamination problems can include excessive delay, inappropriate temperature, leakage, insufficient quantity, incorrect container or additive, visible clotting where an anticoagulated specimen is required, or other integrity concerns. The significance of each condition depends on the examination and the laboratory's validated procedures.
8. Specimen Receipt, Accessioning, and Suitability Assessment
When the specimen arrives in the laboratory, personnel or automated systems verify that the request and specimen are compatible and that acceptance criteria are met. Common checkpoints include:
- patient and specimen identifiers;
- requested examination and specimen type;
- container or additive;
- collection and receipt information when required;
- specimen volume or fill requirements;
- transport and storage conditions;
- visible integrity concerns; and
- test-specific stability or processing requirements.
If a specimen does not meet requirements, the laboratory must follow its nonconforming-specimen procedure. Depending on the situation and the risk of delay, this may involve rejection and recollection, documented acceptance with qualification, consultation with clinical staff, or another validated pathway.
9. Processing Before Examination
Many specimens require preparation before the actual measurement. Blood specimens may require clot formation, centrifugation, separation of serum or plasma, aliquoting, mixing, or storage at specified conditions. Other specimen types may require homogenization, concentration, staining, culture preparation, or nucleic-acid extraction.
These are not merely logistical steps. Processing can influence the material presented to the analytical system and therefore must be standardized and controlled.
10. The Examination Phase
The examination phase is the part most people associate with “laboratory testing,” but it is only one component of the total process. During examination, the laboratory applies a validated or verified measurement procedure using qualified equipment, appropriate reagents, competent personnel, and defined quality controls.
Important analytical controls can include:
- instrument maintenance and function checks;
- calibration or calibration verification where applicable;
- internal quality-control procedures;
- reagent and lot management;
- environmental conditions relevant to the method;
- method-specific acceptance criteria;
- review of instrument flags, errors, or analytical warnings; and
- participation in external quality assessment or proficiency testing where applicable.
A quality-control result is not a patient result. It is evidence used to assess whether an analytical system is performing acceptably before or while patient results are released according to the laboratory's quality-control strategy.
11. Analytical Results Still Require Context
Modern analyzers can generate large amounts of precise data rapidly, but laboratory professionals must still evaluate whether results are technically plausible and consistent with method limitations, specimen characteristics, instrument messages, previous results when available, and laboratory review rules.
For example, a complete blood count (CBC) may produce numeric parameters together with analyzer flags. Depending on laboratory criteria, unusual relationships, abnormal histograms, suspected platelet clumping, or flagged leukocyte populations may trigger repeat analysis, dilution, alternative procedures, or peripheral smear review.
The goal is not to manually challenge every result. The goal is to apply validated rules that distinguish routine results from findings that require additional technical review.
12. Result Verification and Authorization
Before a result becomes part of the clinical record, the laboratory must ensure that reporting requirements have been satisfied. Depending on the laboratory system, verification may be manual, automated, or a combination of both.
Verification can consider quality-control status, instrument flags, reportable ranges, dilution factors, specimen comments, consistency checks, prior results, and other laboratory-defined criteria. Automated verification can improve efficiency, but only when the rules have been validated and are monitored.
13. Reference Intervals, Decision Limits, and Interpretive Information
A result is meaningful only when it is interpreted using the correct framework. Reports may include reference intervals, clinical decision limits, interpretive comments, units, method-related notes, or other information needed to prevent misinterpretation.
Reference intervals and clinical decision limits are not interchangeable concepts. A reference interval generally describes values observed in a defined reference population, whereas a clinical decision limit is selected for a specific diagnostic or management purpose. Laboratories should report and use these according to the evidence and requirements applicable to the examination.
14. Critical and Significant-Risk Results
Some laboratory findings require accelerated communication because delay in clinical review could create substantial risk. CLSI GP47 describes systems for identifying and communicating critical and significant-risk results, emphasizing defined policies, responsibilities, escalation processes, monitoring, and timely reporting.
The exact list of results requiring urgent notification, the thresholds used, who may receive them, and how communication is documented should be established by the organization based on its patient population, services, and applicable requirements. There is no single universal list appropriate for every clinical environment.
15. Reporting the Result
Postexamination reporting should deliver the correct result to the correct destination in a form that is understandable and traceable. A laboratory report commonly includes patient identifiers, examination names, results, units where applicable, reference information, specimen or collection information when relevant, and any interpretive or technical comments required for safe use.
Electronic transmission through a laboratory information system or electronic health record reduces many manual steps, but reporting systems still require validation, access control, data integrity safeguards, and procedures for amended or corrected reports.
16. The Process Continues After Reporting
The laboratory's responsibility does not necessarily end when the result appears on a screen. Postexamination activities can include retention and disposal of specimens, record retention, amended reports, consultation, monitoring of turnaround times, review of nonconformities, and quality-improvement activities.
Quality management therefore treats the laboratory as a system rather than a collection of isolated instruments. ISO 15189:2022 specifies requirements for quality and competence in medical laboratories, reinforcing the importance of controlled processes across the laboratory service.
17. A Practical Example: Following a CBC Specimen
Consider a patient for whom a CBC is requested:
- The correct patient and examination are identified.
- The patient is prepared according to relevant instructions.
- Venous blood is collected into the appropriate anticoagulant tube using the validated procedure.
- The specimen is labeled and transported under acceptable conditions.
- The laboratory receives the specimen and evaluates identification, volume, clotting, and other suitability criteria.
- The specimen is mixed and analyzed according to the laboratory's hematology procedure.
- Quality-control and analyzer status are acceptable.
- The analyzer produces the CBC and differential data, including any flags.
- Laboratory review rules determine whether the result can be released directly or requires additional investigation, such as a smear review.
- The verified result is transmitted to the appropriate clinical record, and any result meeting urgent-notification criteria is communicated according to policy.
The numerical CBC result is therefore only one link in a much larger chain of quality and patient-safety decisions.
18. Where Errors Can Be Prevented
Rather than treating laboratory errors as events that occur only at the analyzer, quality systems look for vulnerabilities throughout the entire pathway. High-value prevention strategies include standardized procedures, competency assessment, positive patient identification, specimen acceptance criteria, validated transport and processing conditions, effective quality control, reliable information systems, clear critical-result communication, and systematic review of nonconforming events.
When a problem occurs, the objective is not simply to correct one result. A mature quality system asks whether the process itself needs to change so that recurrence becomes less likely.
19. Key Takeaways
- A laboratory result is the output of an end-to-end system, not just an analyzer measurement.
- The total testing process includes preexamination, examination, and postexamination activities.
- Correct patient identification and specimen labeling are fundamental safety controls.
- Specimen integrity depends on test-specific requirements for collection, transport, processing, and storage.
- Analytical quality requires controlled methods, competent personnel, equipment oversight, and quality-control procedures.
- Result verification, appropriate reporting, and timely communication of urgent findings are part of laboratory quality.
- Quality improvement should examine the entire process when nonconformities occur.
Continue Learning with Soleil Academy™
For a deeper application of these principles in hematology, read Complete Blood Count (CBC): A Comprehensive Guide to Interpretation and Clinical Significance. Professionals preparing for certification can also review How to Prepare for the ASCP MLS and MLT Certification Exams.
Selected Standards and Authoritative Resources
- International Organization for Standardization. ISO 15189:2022 — Medical laboratories — Requirements for quality and competence.
- Clinical and Laboratory Standards Institute. PRE02, 8th ed. — Collection of Diagnostic Venous Blood Specimens. Published February 13, 2025.
- Clinical and Laboratory Standards Institute. PRE04, 1st ed. — Handling, Transport, Processing, and Storage of Blood Specimens for Routine Laboratory Examinations. Published August 3, 2023.
- Clinical and Laboratory Standards Institute. GP47 — Management of Critical- and Significant-Risk Results. Published October 30, 2015; confirmed for continued publication.
- World Health Organization. Laboratory Quality Management System: Handbook. Geneva: WHO.
Educational disclaimer: This article is intended for scientific education and professional development. It does not replace validated institutional procedures, manufacturer instructions, applicable regulations, accreditation requirements, or individualized clinical judgment.
Soleil Academy™ — Advancing Scientific Knowledge. Empowering the Next Generation of Professionals.